A systematic review examining the relationship between cytokines and cachexia in incurable cancer
Abstract Cancer cachexia is an unmet clinical need that affects more than 50% of patients with cancer. The systemic inflammatory response, which is mediated by a network of cytokines, has an established role in the genesis and maintenance of cancer as well as in cachexia; yet, the specific role of t...
Main Authors: | D. Robert Paval, Rebekah Patton, James McDonald, Richard J.E. Skipworth, Iain J. Gallagher, Barry J. Laird, the Caledonian Cachexia Collaborative |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-04-01
|
Series: | Journal of Cachexia, Sarcopenia and Muscle |
Subjects: | |
Online Access: | https://doi.org/10.1002/jcsm.12912 |
Similar Items
-
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
by: Leo R. Brown, et al.
Published: (2024-06-01) -
Cancer cachexia
by: Kunze Philipp, et al.
Published: (2003-11-01) -
Optimising Outcomes in Non Small Cell Lung Cancer: Targeting Cancer Cachexia
by: Iain Phillips, et al.
Published: (2022-04-01) -
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
by: Michael S. Yule, et al.
Published: (2024-06-01) -
Adipose depot gene expression and intelectin‐1 in the metabolic response to cancer and cachexia
by: Janice Miller, et al.
Published: (2020-08-01)